Jenoptik AG
Jenoptik AG Fundamental Analysis
Jenoptik AG (JEN.SW) shows weak financial fundamentals with a PE ratio of 16.69, profit margin of 6.89%, and ROE of 7.53%. The company generates $0.5B in annual revenue with weak year-over-year growth of -6.26%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 36.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze JEN.SW's fundamental strength across five key dimensions:
Efficiency Score
WeakJEN.SW struggles to generate sufficient returns from assets.
Valuation Score
ExcellentJEN.SW trades at attractive valuation levels.
Growth Score
WeakJEN.SW faces weak or negative growth trends.
Financial Health Score
ExcellentJEN.SW maintains a strong and stable balance sheet.
Profitability Score
WeakJEN.SW struggles to sustain strong margins.
Key Financial Metrics
Is JEN.SW Expensive or Cheap?
P/E Ratio
JEN.SW trades at 16.69 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, JEN.SW's PEG of -2.25 indicates potential undervaluation.
Price to Book
The market values Jenoptik AG at 1.24 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.15 times EBITDA. This is generally considered low.
How Well Does JEN.SW Make Money?
Net Profit Margin
For every $100 in sales, Jenoptik AG keeps $6.89 as profit after all expenses.
Operating Margin
Core operations generate 10.62 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.53 in profit for every $100 of shareholder equity.
ROA
Jenoptik AG generates $4.37 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Jenoptik AG produces operating cash flow of $83.21M, showing steady but balanced cash generation.
Free Cash Flow
Jenoptik AG produces free cash flow of $43.11M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.59 in free cash annually.
FCF Yield
JEN.SW converts 15.89% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.69
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.25
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.24
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.54
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.56
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How JEN.SW Stacks Against Its Sector Peers
| Metric | JEN.SW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.69 | 33.98 | Better (Cheaper) |
| ROE | 7.53% | 1007.00% | Weak |
| Net Margin | 6.89% | -47797.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.44 | Strong (Low Leverage) |
| Current Ratio | 1.56 | 5.66 | Neutral |
| ROA | 4.37% | -287350.00% (disorted) | Weak |
JEN.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Jenoptik AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
69.95%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
72.38%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
103.50%
Industry Style: Growth, Innovation, High Beta
High Growth